A broad-based and diverse translational research program that is collaborative, multidisciplinary, and interrelated requires specific administrative leadership and support to be successful. The University of Michigan Head and Neck SPORE consists of an ambitious, highly integrated and synergistic program of four major research projects, and a comprehensive program for selection, support and evaluation of pilot research projects and career development awards. Our Administrative Core has been a very successful shared resource that maintains the focus on the translational goals, institutional commitment and adequate infrastructure support for clinical / basic science integrated efforts. The DM H&N SPORE Administration and Translational Trials Support Core has committed significant resources for program organization, coordination, data management, community outreach, computer support and management services necessary to link each project and achieve overall SPORE goals. This Core acts as a central information clearinghouse, and provides organization for all meetings, budgets, financial reporting, data management, quality control, activity reports, problem solving, scientific leadership, and solicitation of new ideas and faculty. Oversight of day-to-day operations of the Tissue Core is provided by this Core and collaborative efforts between all core resources and SPORE projects is facilitated in this office. Patient Advocate activities and initiatives with community physicians in the SPORE Network are coordinated by this Core. The Core is responsible for program evaluation, recruitment and support of Internal and External reviewers, and administrative support and evaluation of the Developmental Research and Career Development Programs. Gregory T. Wolf, M.D., Chair of Otolaryngology- Head and Neck Surgery functions as PI and is responsible for planning and implementation, reporting and assessment of all aspects of the SPORE Program. He has extensive experience in multidisciplinary translational research. The Core is organized to maximize oversight, investigator support, enhance patient care, and electronic data management through the use of formal seminars, meetings and reports. To ensure success, he has committed significant effort (20%) to this Core. The operation of this Core enhances and facilitates the unqualified success of this SPORE effort and thereby has a direct, favorable impact on the treatment, morbidity and mortality of head and neck cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA097248-10
Application #
8382525
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2012
Total Cost
$532,211
Indirect Cost
$87,644
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Wolf, Gregory T; Bellile, Emily; Eisbruch, Avraham et al. (2017) Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer. JAMA Otolaryngol Head Neck Surg 143:355-366
Getz, Kayla R; Rozek, Laura S; Peterson, Lisa A et al. (2017) Family history of cancer and head and neck cancer survival. Laryngoscope 127:1816-1820
Hoban, Connor W; Beesley, Lauren J; Bellile, Emily L et al. (2017) Individualized outcome prognostication for patients with laryngeal cancer. Cancer :
Kim, Hong Sun; Chen, Yu-Chih; Nör, Felipe et al. (2017) Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels. Oncotarget 8:100339-100352
Walline, Heather M; Goudsmit, Christine M; McHugh, Jonathan B et al. (2017) Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck 39:840-852
Kerk, Samuel A; Finkel, Kelsey A; Pearson, Alexander T et al. (2017) 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 23:2516-2527
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188
Udager, A M; McHugh, J B; Goudsmit, C M et al. (2017) Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol :
Gainor, Danielle L; Marchiano, Emily; Bellile, Emily et al. (2017) Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx. Otolaryngol Head Neck Surg 157:625-630
Nör, Felipe; Warner, Kristy A; Zhang, Zhaocheng et al. (2017) Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas. Clin Cancer Res 23:1036-1048

Showing the most recent 10 out of 249 publications